Introduction: Lidet A Negash, a brilliant inventor based in Plainsboro, NJ (US), has made significant contributions to the field of pharmaceuticals with his groundbreaking patents.

Latest Patents: Negash's latest patents include compounds such as Thienopyridines and benzothiophenes useful as IRAK4 inhibitors, designed to modulate IRAK4 and treat inflammatory and autoimmune diseases, as well as cancer. Additionally, his Dihydropyridinone MGAT2 inhibitors target monoacylglycerol acyltransferase type 2 (MGAT2) and show promise as medicaments.

Career Highlights: Negash is a valued member of Bristol-Myers Squibb Company, where his innovative work has led to the development of life-changing pharmaceutical compounds. With a total of 4 patents to his name, he continues to push the boundaries of pharmaceutical research.

Collaborations: Negash collaborates closely with his coworkers Saleem Ahmad and Hao Zhang, pooling their expertise to drive forward cutting-edge pharmaceutical developments within Bristol-Myers Squibb Company.

Conclusion: In conclusion, Lidet A Negash stands as a beacon of innovation in the field of pharmaceuticals, with a track record of patents that have the potential to revolutionize the treatment of various diseases. His contributions to the industry are invaluable, and his dedication to pushing the boundaries of science is truly commendable.

This text is generated by artificial intelligence and may not be accurate.